Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25


Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran.

Kumar P, Gordon LA, Brooks KM, George JM, Kellogg A, McManus M, Alfaro RM, Nghiem K, Lozier J, Hadigan C, Penzak SR.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01201-17. doi: 10.1128/AAC.01201-17. Print 2017 Nov.


Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.

Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D.

PLoS One. 2017 May 2;12(5):e0176527. doi: 10.1371/journal.pone.0176527. eCollection 2017.


Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.

Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R, Eksterman L, Moreira R, Currier JS, Veloso VG, Grinsztejn B, Lake JE.

BMC Infect Dis. 2016 Aug 8;16:376. doi: 10.1186/s12879-016-1735-4.


Lipid Abnormalities and Inflammation in HIV Inflection.

Funderburg NT, Mehta NN.

Curr HIV/AIDS Rep. 2016 Aug;13(4):218-25. doi: 10.1007/s11904-016-0321-0. Review.


Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.

Zidar DA, Juchnowski S, Ferrari B, Clagett B, Pilch-Cooper HA, Rose S, Rodriguez B, McComsey GA, Sieg SF, Mehta NN, Lederman MM, Funderburg NT.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):154-60. doi: 10.1097/QAI.0000000000000566.


Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.

Funderburg NT, Jiang Y, Debanne SM, Labbato D, Juchnowski S, Ferrari B, Clagett B, Robinson J, Lederman MM, McComsey GA.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):396-404. doi: 10.1097/QAI.0000000000000478.


Coagulation and morbidity in treated HIV infection.

Funderburg NT, Lederman MM.

Thromb Res. 2014 May;133 Suppl 1:S21-4. doi: 10.1016/j.thromres.2014.03.012.


Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients.

Funderburg NT.

Curr Opin HIV AIDS. 2014 Jan;9(1):80-6. doi: 10.1097/COH.0000000000000019. Review.


Systemic effects of inflammation on health during chronic HIV infection.

Deeks SG, Tracy R, Douek DC.

Immunity. 2013 Oct 17;39(4):633-45. doi: 10.1016/j.immuni.2013.10.001.


Chronic HIV disease and activation of the coagulation system.

Baker JV.

Thromb Res. 2013 Nov;132(5):495-9. doi: 10.1016/j.thromres.2013.08.016. Epub 2013 Aug 29. Review.


Residual immune dysregulation syndrome in treated HIV infection.

Lederman MM, Funderburg NT, Sekaly RP, Klatt NR, Hunt PW.

Adv Immunol. 2013;119:51-83. doi: 10.1016/B978-0-12-407707-2.00002-3. Review.


Human immunodeficiency virus-associated lung malignancies.

Lambert AA, Merlo CA, Kirk GD.

Clin Chest Med. 2013 Jun;34(2):255-72. doi: 10.1016/j.ccm.2013.01.008. Epub 2013 Apr 8. Review.


Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease.

Freiberg MS, Kraemer KL.

Alcohol Res Health. 2010;33(3):237-46. Review.


Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Kiefer EM, Shi Q, Hoover DR, Kaplan R, Tracy R, Augenbraun M, Liu C, Nowicki M, Tien PC, Cohen M, Golub ET, Anastos K.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):301-10. doi: 10.1097/QAI.0b013e31827fdd61.


Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source.

McGinnis KA, Brandt CA, Skanderson M, Justice AC, Shahrir S, Butt AA, Brown ST, Freiberg MS, Gibert CL, Goetz MB, Kim JW, Pisani MA, Rimland D, Rodriguez-Barradas MC, Sico JJ, Tindle HA, Crothers K.

Nicotine Tob Res. 2011 Dec;13(12):1233-9. doi: 10.1093/ntr/ntr206. Epub 2011 Sep 12.


HIV-Associated Venous Thromboembolism.

Bibas M, Biava G, Antinori A.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011030. doi: 10.4084/MJHID.2011.030. Epub 2011 Jul 8.


Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.

Musselwhite LW, Sheikh V, Norton TD, Rupert A, Porter BO, Penzak SR, Skinner J, Mican JM, Hadigan C, Sereti I.

AIDS. 2011 Mar 27;25(6):787-95. doi: 10.1097/QAD.0b013e3283453fcb.


Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Lifson AR; INSIGHT Endpoint Review Committee Writing Group, Belloso WH, Davey RT, Duprez D, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson JH, Worley J, INSIGHT Study Group.

HIV Clin Trials. 2010 Jul-Aug;11(4):205-19. doi: 10.1310/hct1104-205.


The Relationship Between HIV Infection and Cardiovascular Disease.

Dau B, Holodniy M.

Curr Cardiol Rev. 2008 Aug;4(3):203-18. doi: 10.2174/157340308785160589.

Supplemental Content

Support Center